Botulinum neurotoxin-A in idiopathic chondrolysis: A report of two cases

7Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Two cases of idiopathic chondrolysis were treated by botulinum neurotoxin-A injections, with a favorable outcome. The treatment consisted of botulinum neurotoxin-A injections, followed by an intensive rehabilitation program. No surgery was needed. Both patients were symptom-free and showed an extremely satisfactory range of motion. Radiographs indicated reconstitution of the joint space in both cases. We believe that botulinum neurotoxin-A injections combined with an intensive rehabilitation program may be considered a new potential management modality and is worth attempting and studying when one considers the results of previously published reports. © Lippincott Williams & Wilkins.

Cite

CITATION STYLE

APA

Khoshhal, K. I., Awaad, Y., & Abbak, A. A. (2014). Botulinum neurotoxin-A in idiopathic chondrolysis: A report of two cases. Journal of Pediatric Orthopaedics Part B, 23(5), 441–446. https://doi.org/10.1097/BPB.0000000000000076

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free